glp 1 latest news Overdose risks increase as demand for injectable weight-loss drugs on the rise, research finds CMS Extends Medicare's Short-Term Bridge

Results from the OUTSTAND-1 trial showed Hengrui/Kailera's HRS-7535 (KAI-7535) cut HbA1c by a highest placebo-adjusted 1.62% at 32 weeks, based on the treatment efficacy estimand.

[Instructions of Use - How To Take It] Take the berberine supplement 5-15 minutes before your first meal of the day

Most of my patients have never heard of this common problem

Common nutritional concerns associated with GLP-1 therapy may include: Reduced appetite and inadequate nutrient intake Loss of lean muscle mass during rapid weight reduction Nausea, digestive discomfort, and poor food tolerance Fatigue and reduced energy levels Micronutrient deficiencies over long-term use Increased nutritional needs in patients with complex clinical conditions Effective GLP-1 treatment requires more than medication alone